These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 31219558)

  • 1. A Randomized Placebo-Controlled Trial of Low-Dose Testosterone Therapy in Women With Anorexia Nervosa.
    Kimball A; Schorr M; Meenaghan E; Bachmann KN; Eddy KT; Misra M; Lawson EA; Kreiger-Benson E; Herzog DB; Koman S; Keane RJ; Ebrahimi S; Schoenfeld D; Klibanski A; Miller KK
    J Clin Endocrinol Metab; 2019 Oct; 104(10):4347-4355. PubMed ID: 31219558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen deficiency: association with increased anxiety and depression symptom severity in anorexia nervosa.
    Miller KK; Wexler TL; Zha AM; Lawson EA; Meenaghan EM; Misra M; Binstock AB; Herzog DB; Klibanski A
    J Clin Psychiatry; 2007 Jun; 68(6):959-65. PubMed ID: 17592924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind, placebo-controlled study of testosterone treatment in hypogonadal older men with subthreshold depression (dysthymia or minor depression).
    Shores MM; Kivlahan DR; Sadak TI; Li EJ; Matsumoto AM
    J Clin Psychiatry; 2009 Jul; 70(7):1009-16. PubMed ID: 19653976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of risedronate and low-dose transdermal testosterone on bone mineral density in women with anorexia nervosa: a randomized, placebo-controlled study.
    Miller KK; Meenaghan E; Lawson EA; Misra M; Gleysteen S; Schoenfeld D; Herzog D; Klibanski A
    J Clin Endocrinol Metab; 2011 Jul; 96(7):2081-8. PubMed ID: 21525157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testosterone therapy in late-life major depression in males.
    Perry PJ; Yates WR; Williams RD; Andersen AE; MacIndoe JH; Lund BC; Holman TL
    J Clin Psychiatry; 2002 Dec; 63(12):1096-101. PubMed ID: 12523867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 2: improvement in psychiatric measures.
    Hedges DW; Reimherr FW; Hoopes SP; Rosenthal NR; Kamin M; Karim R; Capece JA
    J Clin Psychiatry; 2003 Dec; 64(12):1449-54. PubMed ID: 14728106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
    Tourian KA; Padmanabhan SK; Groark J; Brisard C; Farrington D
    Clin Ther; 2009 Jun; 31 Pt 1():1405-23. PubMed ID: 19698901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chamomile (Matricaria recutita) may provide antidepressant activity in anxious, depressed humans: an exploratory study.
    Amsterdam JD; Shults J; Soeller I; Mao JJ; Rockwell K; Newberg AB
    Altern Ther Health Med; 2012; 18(5):44-9. PubMed ID: 22894890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized controlled trial of sertraline for the treatment of depression in persons with traumatic brain injury.
    Ashman TA; Cantor JB; Gordon WA; Spielman L; Flanagan S; Ginsberg A; Engmann C; Egan M; Ambrose F; Greenwald B
    Arch Phys Med Rehabil; 2009 May; 90(5):733-40. PubMed ID: 19406291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind, placebo-controlled, exploratory trial of chromium picolinate in atypical depression: effect on carbohydrate craving.
    Docherty JP; Sack DA; Roffman M; Finch M; Komorowski JR
    J Psychiatr Pract; 2005 Sep; 11(5):302-14. PubMed ID: 16184071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial.
    Gelenberg AJ; Lydiard RB; Rudolph RL; Aguiar L; Haskins JT; Salinas E
    JAMA; 2000 Jun; 283(23):3082-8. PubMed ID: 10865302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone replacement therapy for hypogonadal men with major depressive disorder: a randomized, placebo-controlled clinical trial.
    Seidman SN; Spatz E; Rizzo C; Roose SP
    J Clin Psychiatry; 2001 Jun; 62(6):406-12. PubMed ID: 11465516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of physiologic estrogen replacement on anxiety symptoms, body shape perception, and eating attitudes in adolescent girls with anorexia nervosa: data from a randomized controlled trial.
    Misra M; Katzman DK; Estella NM; Eddy KT; Weigel T; Goldstein MA; Miller KK; Klibanski A
    J Clin Psychiatry; 2013 Aug; 74(8):e765-71. PubMed ID: 24021517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quetiapine in the treatment of anxiety in patients with bipolar I or II depression: a secondary analysis from a randomized, double-blind, placebo-controlled study.
    Hirschfeld RM; Weisler RH; Raines SR; Macfadden W;
    J Clin Psychiatry; 2006 Mar; 67(3):355-62. PubMed ID: 16649820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of St John's wort in major depression: a randomized controlled trial.
    Shelton RC; Keller MB; Gelenberg A; Dunner DL; Hirschfeld R; Thase ME; Russell J; Lydiard RB; Crits-Cristoph P; Gallop R; Todd L; Hellerstein D; Goodnick P; Keitner G; Stahl SM; Halbreich U
    JAMA; 2001 Apr; 285(15):1978-86. PubMed ID: 11308434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind, placebo-controlled study of risperidone for the treatment of adolescents and young adults with anorexia nervosa: a pilot study.
    Hagman J; Gralla J; Sigel E; Ellert S; Dodge M; Gardner R; O'Lonergan T; Frank G; Wamboldt MZ
    J Am Acad Child Adolesc Psychiatry; 2011 Sep; 50(9):915-24. PubMed ID: 21871373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D-Cycloserine facilitation of exposure therapy improves weight regain in patients with anorexia nervosa: a pilot randomized controlled trial.
    Levinson CA; Rodebaugh TL; Fewell L; Kass AE; Riley EN; Stark L; McCallum K; Lenze EJ
    J Clin Psychiatry; 2015 Jun; 76(6):e787-93. PubMed ID: 26132687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deep brain stimulation of the subcallosal cingulate for treatment-refractory anorexia nervosa: 1 year follow-up of an open-label trial.
    Lipsman N; Lam E; Volpini M; Sutandar K; Twose R; Giacobbe P; Sodums DJ; Smith GS; Woodside DB; Lozano AM
    Lancet Psychiatry; 2017 Apr; 4(4):285-294. PubMed ID: 28238701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.